Collaboration over at least three years aims to help understand how pre-cancerous cells develop
Business live – latest updates
GSK has said it will spend £50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers.
The FTSE 100 pharmaceutical company said that the GSK-Oxford Cancer Immuno-Prevention Programme will look at how pre-cancerous cells develop.
More Stories
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Elon Musk’s company town: SpaceX employees vote to create ‘Starbase’
Please welcome to the stage … Anita Dump! The Facebook group with the best and worst drag names